TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,064,000 | -49.2% | 337,609 | -8.0% | 0.05% | -41.0% |
| Q4 2021 | $17,839,000 | -32.4% | 366,837 | -7.7% | 0.08% | -34.5% |
| Q3 2021 | $26,406,000 | -21.3% | 397,502 | -7.6% | 0.12% | -17.4% |
| Q2 2021 | $33,572,000 | -13.0% | 430,300 | +1.0% | 0.14% | -15.8% |
| Q1 2021 | $38,579,000 | -17.2% | 425,873 | +11.4% | 0.17% | -35.0% |
| Q4 2020 | $46,596,000 | +19.6% | 382,411 | -13.1% | 0.26% | +30.8% |
| Q3 2020 | $38,946,000 | +37.5% | 439,823 | -0.7% | 0.20% | +24.8% |
| Q2 2020 | $28,315,000 | +459.1% | 442,714 | +290.4% | 0.16% | +403.1% |
| Q1 2020 | $5,064,000 | – | 113,407 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |